Vacc-CRX

N/A

Report date: 2025/03/20 09:46:25

Base Information

Drug NameVacc-CRX
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionC-C chemokine receptor type 5 antagonistsHIV envelope protein gp120 inhibitorsC-X-C motif chemokine receptor 4 antagonists
TargetsHIV envelope protein gp120C-C chemokine receptor type 5C-X-C motif chemokine receptor 4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBionor Holding As
China Registration ClassN/A

Develop Information

Active CompaniesBionor Holding As
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A